Image 2_Pharmacogenetic variations and clinical implications of actionable CYP2D6/CYP2C19 variants in Central Indian patients with common mental disorders.tif

Image 2_Pharmacogenetic variations and clinical implications of actionable CYP2D6/CYP2C19 variants in Central Indian patients with common mental disorders.tif

Introduction<p>Genetic polymorphisms in CYP2D6 and CYP2C19 significantly influence the metabolism, efficacy, and safety of antidepressant medications. Limited data exist on the prevalence of these actionable pharmacogenetic variants in the Central Indian population. This study aimed to determi...

Description complète

Enregistré dans:
Détails bibliographiques
Auteur principal: Santenna Chenchula (14775163) (author)
Autres auteurs: Atal Shubham (22679330) (author), Rozatkar Abhijit (22679333) (author), Tamonud Modak (22679336) (author), Kohat Komal (22679339) (author), Ratinder Jhaj (22679342) (author), Singh Jitendra (22679345) (author), Satyaprakash V. (22679348) (author), Sadasivam Balakrishnan (22679351) (author)
Publié: 2025
Sujets:
Pharmacology
pharmacogenetics
CYP2D6
CYP2C19
antidepressants
common mental disorders
indian population
copy number variation
CPIC
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires